文献速递口腔修复与种植牙周病

结缔组织移植物与胶原基质增加单颗种植体颊侧软组织厚度的多中心随机对照试验:3年结果

A multi-centre randomized controlled trial comparing connective tissue graft with collagen matrix to increase soft tissue thickness at the buccal aspect of single implants: 3-Year results.
PubMed 文献 · J Clin Periodontol · 2024-03-14

这项多中心随机对照试验比较结缔组织移植物(CTG)与胶原基质(CMX)在单颗种植体位点增加颊侧软组织轮廓(BSP)的效果。结论认为CTG在增加颊侧软组织轮廓和减少边缘骨丧失方面优于CMX,仍是种植位点增加软组织厚度的金标准。

要点

  • CTG组3年BSP增加0.83 mm,CMX组0.48 mm,组间差异0.35 mm支持CTG。
  • 两组在患者美学满意度、探诊深度、出血、PES等指标上无显著差异。

核心结论

  • CTG在增加单颗种植体颊侧软组织轮廓方面比CMX更有效,且边缘骨丧失更少。
  • CTG仍是增加种植位点软组织厚度的金标准。

研究设计与样本

  • 多中心随机对照试验,纳入上前牙单颗缺牙且水平黏膜缺损、已完全愈合、颊腭骨宽度至少6 mm的患者。
  • 所有患者接受全数字化流程的即刻修复单颗种植体,随机分为对照组(CTG)和试验组(CMX:Geistlich Fibro-Gide)。

主要发现

  • BSP随时间变化组间差异显著(p < .001)。
  • 3年时BSP估计平均增加:对照组0.83 mm(95%CI 0.58-1.08),试验组0.48 mm(95%CI 0.22-0.73)。
  • 组间估计平均差异0.35 mm(95%CI 0.06-0.65)支持对照组,差异显著(p = .021)。
  • CMX组边缘骨丧失显著多于CTG组(-0.43 mm;95%CI -0.77至-0.09;p = .015)。
  • 两组在患者美学满意度(p = .563)、探诊深度(p = .286)、菌斑(p = .676)、探诊出血(p = .732)、中面部退缩(p = .667)、PES(p = .366)和黏膜瘢痕指数(p = .438)方面无显著差异。

临床怎么用

  • 对于上前牙单颗种植体需增加颊侧软组织厚度时,优先考虑结缔组织移植物(CTG)。
  • 若使用胶原基质(CMX),需注意其边缘骨丧失可能多于CTG。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To compare connective tissue graft (CTG) with collagen matrix (CMX) in terms of increase in buccal soft tissue profile (BSP) when applied at single implant sites. MATERIALS AND METHODS: Patients with a single tooth gap in the anterior maxilla and horizontal mucosa defect were enrolled in a multi-centre randomized controlled trial. All were fully healed sites with a bucco-palatal bone dimension of at least 6 mm, and received an immediately restored single implant using a full digital workflow. Patients were randomly allocated to the control (CTG) or test group (CMX: Geistlich Fibro-Gide, Geistlich Pharma AG, Wolhusen, Switzerland) to increase buccal soft tissue thickness. Primary endpoints were increase in BSP at T1 (immediately postop), T2 (3 months), T3 (1 year) and T4 (3 years) based on superimposed digital surface models. Secondary endpoints included patient-reported, clinical and aesthetic outcomes. RESULTS: Thirty patients were included per group (control group: 15 males, 15 females, mean age 50.1 years; test group: 14 males, 16 females, mean age 48.2 years) and 50 could be re-examined at T4. The changes in BSP over time were significantly different between the groups (p < .001). At T4, the estimated mean increase in BSP amounted to 0.83 mm (95% confidence interval [CI]: 0.58-1.08) in the control group and 0.48 mm (95% CI: 0.22-0.73) in the test group. The estimated mean difference of 0.35 mm (95% CI: 0.06-0.65) in favour of the control group was significant (p = .021). No significant differences between the groups could be observed in terms of patients' aesthetic satisfaction (p = .563), probing depth (p = .286), plaque (p = .676), bleeding on probing (p = .732), midfacial recession (p = .667), Pink Esthetic Score (p = .366) and Mucosal Scarring Index (p = .438). However, CMX resulted in significantly more marginal bone loss (-0.43 mm; 95% CI: -0.77 to -0.09; p = .015) than CTG. CONCLUSIONS: CTG was more effective in increasing buccal soft tissue profile and resulted in less marginal bone loss than CMX. Therefore, CTG remains the gold standard to increase soft tissue thickness at implant sites. CLINICAL TRIAL REGISTRATION: This study was registered in ClinicalTrials.gov (NCT04210596).

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Surdiacourt L, Christiaens V, De Bruyckere T, et al. A multi-centre randomized controlled trial comparing connective tissue graft with collagen matrix to increase soft tissue thickness at the buccal aspect of single implants: 3-Year results. J Clin Periodontol. 2024. PMID: 38485651. doi:10.1111/jcpe.13975

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。